Summit Therapeutics Inc.SMMTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-322.93M
↓ 325% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-76.04M
Historical baseline
PeriodValueYoY Change
2025$-322.93M-127.2%
2024$-142.11M-85.1%
2023$-76.76M-84.6%
2022$-41.58M+42.7%
2021$-72.59M-50.9%
2020$-48.11M-209.1%
2019$-15.56M+55.7%
2018$-35.14M-69.0%
2017$-20.79M-237.0%
2016$15.18M-